Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

OtherReview Articles

Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features

W.S. Bartynski
American Journal of Neuroradiology June 2008, 29 (6) 1036-1042; DOI: https://doi.org/10.3174/ajnr.A0928
W.S. Bartynski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. ↵
    Colosimo C Jr, Fileni A, Moschini M, et al. CT findings in eclampsia. Neuroradiology 1985;27:313–17
    CrossRefPubMedWeb of Science
  2. ↵
    Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59–64
    CrossRefPubMedWeb of Science
  3. ↵
    Naheedy MH, Biller J, Schiffer M, et al. Toxemia of pregnancy: cerebral CT findings. J Comput Assist Tomogr 1985;9:497–501
    PubMedWeb of Science
  4. ↵
    Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–29
    Abstract/FREE Full Text
  5. ↵
    Waldron RL 2nd, Abbott DC, Vellody D, et al. Computed tomography in preeclampsia-eclampsia syndrome. AJNR Am J Neuroradiol 1985;6:442–43
    FREE Full Text
  6. ↵
    Fisher M, Maister B, Jacobs R. Hypertensive encephalopathy: diffuse reversible white matter CT abnormalities. Ann Neurol 1985;18:268–70
    PubMedWeb of Science
  7. Rail DL, Perkin GD. Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol 1980;37:310–11
    CrossRefPubMedWeb of Science
  8. ↵
    Weingarten K, Barbut D, Filippi C, et al. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994;162:665–70
    CrossRefPubMedWeb of Science
  9. ↵
    de Groen PC, Aksamit AJ, Rakela J, et al. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987;317:861–66
    CrossRefPubMedWeb of Science
  10. Ghalie R, Fitzsimmons WE, Bennett D, et al. Cortical blindness: a rare complication of cyclosporine therapy. Bone Marrow Transplant 1990;6:147–49
    PubMedWeb of Science
  11. ↵
    Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393–401
    PubMedWeb of Science
  12. ↵
    Truwit CL, Denaro CP, Lake JR, et al. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 1991;12:651–59
    Abstract/FREE Full Text
  13. ↵
    Wilson SE, de Groen PC, Aksamit AJ, et al. Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol 1988;8:215–20
    PubMed
  14. ↵
    Will AD, Lewis KL, Hinshaw DB, et al. Cerebral vasoconstriction in toxemia. Neurology 1987;37:1555–57
    Abstract/FREE Full Text
  15. ↵
    Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
    CrossRefPubMedWeb of Science
  16. ↵
    Bartynski WS, Grabb BC, Zeigler Z, et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997;21:872–80
    CrossRefPubMed
  17. ↵
    Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14
    Abstract/FREE Full Text
  18. ↵
    Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31
    CrossRefPubMedWeb of Science
  19. ↵
    Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369–76
    Abstract/FREE Full Text
  20. ↵
    Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038–48
    Abstract/FREE Full Text
  21. ↵
    Koch S, Rabinstein A, Falcone S, et al. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol 2001;22:1068–70
    Abstract/FREE Full Text
  22. ↵
    Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–65
    CrossRefPubMedWeb of Science
  23. Provenzale JM, Petrella JR, Cruz LC Jr, et al. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455–61
    Abstract/FREE Full Text
  24. ↵
    Schaefer PW, Buonanno FS, Gonzalez RG, et al. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082–85
    Abstract/FREE Full Text
  25. ↵
    Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol 1992;167:935–41
    PubMedWeb of Science
  26. ↵
    Raroque HG Jr, Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology 1990;40:167–69
    Abstract/FREE Full Text
  27. ↵
    Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2007;28:1320–27
    Abstract/FREE Full Text
  28. Oliverio PJ, Restrepo L, Mitchell SA, et al. Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. AJNR Am J Neuroradiol 2000;21:1251–54
    Abstract/FREE Full Text
  29. Casey SO, Truwit CL. Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy? AJNR Am J Neuroradiol 2000;21:243–45
    FREE Full Text
  30. de Seze J, Mastain B, Stojkovic T, et al. Unusual MR findings of the brain stem in arterial hypertension. AJNR Am J Neuroradiol 2000;21:391–94
    Abstract/FREE Full Text
  31. ↵
    Keswani SC, Wityk R. Don't throw in the towel! A case of reversible coma. J Neurol Neurosurg Psychiatry 2002;73:83–84
    Abstract/FREE Full Text
  32. ↵
    McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007;189:904–12
    CrossRefPubMedWeb of Science
  33. ↵
    Keyserling HF, Provenzale JM. Atypical imaging findings in a near-fatal case of posterior reversible encephalopathy syndrome in a child. AJR Am J Roentgenol 2007;188:219–21
    CrossRefPubMed
  34. ↵
    Nussbaum ES, Maxwell RE, Bitterman PB, et al. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression: case report. J Neurosurg 1995;82:1068–70
    PubMedWeb of Science
  35. ↵
    Lin KL, Hsu WC, Wang HS, et al. Hypertension-induced cerebellar encephalopathy and hydrocephalus in a male. Pediatr Neurol 2006;34:72–75
    CrossRefPubMed
  36. ↵
    Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90
    Abstract/FREE Full Text
  37. ↵
    Gijtenbeek JM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol 1999;246:339–46
    CrossRefPubMedWeb of Science
  38. ↵
    Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J 2001;77:24–28
    Abstract/FREE Full Text
  39. ↵
    Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049–54, discussion 1054–55
    CrossRefPubMedWeb of Science
  40. ↵
    Furukawa M, Terae S, Chu BC, et al. MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology 2001;43:615–21
    CrossRefPubMedWeb of Science
  41. Ishikura K, Ikeda M, Hamasaki Y, et al. Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 2006;48:231–38
    CrossRefPubMedWeb of Science
  42. ↵
    Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361–64
    PubMed
  43. ↵
    Hypertensive disorders of pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, eds. Williams Obstetrics. 21st ed. New York: McGraw Hill;2001 :567–618
  44. ↵
    Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75
    CrossRefPubMedWeb of Science
  45. ↵
    Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018–24
    Abstract/FREE Full Text
  46. ↵
    Zoja C, Furci L, Ghilardi F, et al. Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55:455–62
    PubMedWeb of Science
  47. ↵
    Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247–53
    PubMedWeb of Science
  48. ↵
    Haire WD. The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation. Semin Thromb Hemost 1999;25:223–37
    PubMed
  49. ↵
    Sanders TG, Clayman DA, Sanchez-Ramos L, et al. Brain in eclampsia: MR imaging with clinical correlation. Radiology 1991;180:475–78
    PubMedWeb of Science
  50. ↵
    Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000;217:371–76
    CrossRefPubMedWeb of Science
  51. ↵
    Bartynski WS, Sanghvi A. Neuroimaging of delayed eclampsia: report of 3 cases and review of the literature. J Comput Assist Tomogr 2003;27:699–713
    CrossRefPubMedWeb of Science
  52. ↵
    Delefosse D, Samain E, Helias A, et al. Late onset of cortical blindness in a patient with severe preeclampsia related to retained placental fragments. Anesthesiology 2003;98:261–63
    CrossRefPubMed
  53. ↵
    Malow BA, Sandson TA, Schwartz RB. Reversible MRI lesions in eclampsia with hydatidiform mole. Neurology 1990;40:1471–72
    FREE Full Text
  54. ↵
    Aeby A, David P, Fricx C, et al. Posterior reversible encephalopathy syndrome revealing acute post-streptococcal glomerulonephritis. J Child Neurol 2006;21:250–51
    Abstract/FREE Full Text
  55. Ozcakar ZB, Ekim M, Fitoz S, et al. Hypertension induced reversible posterior leukoencephalopathy syndrome: a report of two cases. Eur J Pediatr 2004;163:728–30
    CrossRefPubMedWeb of Science
  56. ↵
    Yano Y, Kario K, Fukunaga T, et al. A case of reversible posterior leukoencephalopathy syndrome caused by transient hypercoagulable state induced by infection. Hypertens Res 2005;28:619–23
    CrossRefPubMedWeb of Science
  57. ↵
    Kur JK, Esdaile JM. Posterior reversible encephalopathy syndrome: an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 2006;33:2178–83
    Abstract/FREE Full Text
  58. Magnano MD, Bush TM, Herrera I, et al. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum 2006;35:396–402
    CrossRefPubMedWeb of Science
  59. Primavera A, Audenino D, Mavilio N, et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rheum Dis 2001;60:534–37
    Abstract/FREE Full Text
  60. ↵
    Thaipisuttikul I, Phanthumchinda K. Recurrent reversible posterior leukoencephalopathy in a patient with systemic lupus erythematosus. J Neurol 2005;252:230–31
    CrossRefPubMedWeb of Science
  61. ↵
    Cooney MJ, Bradley WG, Symko SC, et al. Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders—report of three cases. Radiology 2000;214:711–16
    PubMedWeb of Science
  62. Morris EB, Laningham FH, Sandlund JT, et al. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152–59
    CrossRefPubMedWeb of Science
  63. ↵
    Sanchez-Carpintero R, Narbona J, Lopez de Mesa R, et al. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr Neurol 2001;24:145–48
    CrossRefPubMedWeb of Science
  64. ↵
    Pihko H, Tyni T, Virkola K, et al. Transient ischemic cerebral lesions during induction chemotherapy for acute lymphoblastic leukemia. J Pediatr 1993;123:718–24
    CrossRefPubMedWeb of Science
  65. ↵
    Kishi Y, Miyakoshi S, Kami M, et al. Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant 2004;10:561–68
    CrossRefPubMedWeb of Science
  66. ↵
    Wong R, Beguelin GZ, de Lima M, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2003;122:128–34
    CrossRefPubMedWeb of Science
  67. ↵
    Zimmer WE, Hourihane JM, Wang HZ, et al. The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 1998;19:601–08, discussion 609–10
    Abstract
  68. ↵
    Kanekiyo T, Hara J, Matsuda-Hashii Y, et al. Tacrolimus-related encephalopathy following allogeneic stem cell transplantation in children. Int J Hematol 2005;81:264–68
    CrossRefPubMed
  69. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69
    Abstract/FREE Full Text
  70. ↵
    Bartynski WS, Zeigler ZR, Shadduck RK, et al. Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation. Neurocrit Care 2005;3:33–45
    CrossRefPubMed
  71. Chohan R, Vij R, Adkins D, et al. Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity. Br J Haematol 2003;123:110–13
    CrossRefPubMed
  72. ↵
    Provenzale JM, Graham ML. Reversible leukoencephalopathy associated with graft-versus-host disease: MR findings. AJNR Am J Neuroradiol 1996;17:1290–94
    Abstract
  73. ↵
    Jarosz JM, Howlett DC, Cox TC, et al. Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997;39:711–15
    CrossRefPubMedWeb of Science
  74. Small SL, Fukui MB, Bramblett GT, et al. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol 1996;40:575–80
    CrossRefPubMedWeb of Science
  75. Appignani BA, Bhadelia RA, Blacklow SC, et al. Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol 1996;166:683–88
    PubMedWeb of Science
  76. ↵
    Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leukoencephalopathy following organ transplantation: description of two cases. Clin Neurol Neurosurg 1997;99:222–26
    CrossRefPubMedWeb of Science
  77. ↵
    Shimono T, Miki Y, Toyoda H, et al. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 2003;13:986–93
    PubMedWeb of Science
  78. ↵
    Besenski N, Rumboldt Z, Emovon O, et al. Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 2005;26:2282–89
    Abstract/FREE Full Text
  79. Parvex P, Pinsk M, Bell LE, et al. Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol 2001;16:537–42
    CrossRefPubMedWeb of Science
  80. ↵
    Reinohs M, Straube T, Baum P, et al. Recurrent reversible cerebral edema after long-term immunosuppression with tacrolimus. J Neurol 2002;249:780–81
    CrossRefPubMed
  81. ↵
    Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation 2000;69:467–72
    CrossRefPubMedWeb of Science
  82. ↵
    Wijdicks EF. Neurotoxicity of immunosuppressive drugs. Liver Transpl 2001;7:937–42
    CrossRefPubMedWeb of Science
  83. ↵
    Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008;29:924–30
    Abstract/FREE Full Text
  84. ↵
    Ramanathan V, Helderman JH. Cyclosporine formulations. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :111–21
  85. ↵
    Shapiro R. Tacrolimus. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :123–42
  86. ↵
    Wijdicks EFM. Neurologic manifestations of immunosuppressive agents. In: Wijdicks EFM, ed. Neurologic Complications in Organ Transplant Recipients. Boston: Butterworth-Heinemann;1999 :127–40
  87. ↵
    Furlong T, Storb R, Anasetti C, et al. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant 2000;26:985–91
    CrossRefPubMed
  88. ↵
    Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487–91
    PubMedWeb of Science
  89. ↵
    Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol 1988;45:1078–83
    CrossRefPubMedWeb of Science
  90. Jones BV, Egelhoff JC, Patterson RJ. Hypertensive encephalopathy in children. AJNR Am J Neuroradiol 1997;18:101–06
    Abstract
  91. Kwong YL, Yu YL, Lam KS, et al. CT appearance in hypertensive encephalopathy. Neuroradiology 1987;29:215
    CrossRefPubMed
  92. ↵
    Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–83
    CrossRefPubMedWeb of Science
  93. ↵
    Weingarten KL, Zimmerman RD, Pinto RS, et al. Computed tomographic changes of hypertensive encephalopathy. AJNR Am J Neuroradiol 1985;6:395–98
    Abstract/FREE Full Text
  94. ↵
    Chester EM, Agamanolis DP, Banker BQ, et al. Hypertensive encephalopathy: a clinicopathologic study of 20 cases. Neurology 1978;28:928–39
    Abstract/FREE Full Text
  95. ↵
    Sweany JM, Bartynski WS, Boardman JF. “Recurrent” posterior reversible encephalopathy syndrome: report of 3 cases—PRES can strike twice! J Comput Assist Tomogr 2007;31:148–56
    CrossRefPubMedWeb of Science
  96. ↵
    Sibai BM, Sarinoglu C, Mercer BM. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 1992;166 (6 Pt 1):1757–61, discussion 1761–63
    PubMedWeb of Science
  97. ↵
    Schiff D, Lopes MB. Neuropathological correlates of reversible posterior leukoencephalopathy. Neurocrit Care 2005;2:303–05
    CrossRefPubMedWeb of Science
  98. Thyagarajan GK, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997;64:1461–64
    CrossRefPubMedWeb of Science
  99. ↵
    Velu T, Debusscher L, Stryckmans PA. Cyclosporin-associated fatal convulsions. Lancet 1985;1:219
    PubMed
  100. ↵
    Vaughn DJ, Jarvik JG, Hackney D, et al. High-dose cytarabine neurotoxicity: MR findings during the acute phase. AJNR Am J Neuroradiol 1993;14:1014–16
    Abstract/FREE Full Text
  101. ↵
    Koide T, Yamada M, Takahashi T, et al. Cyclosporine A-associated fatal central nervous system angiopathy in a bone marrow transplant recipient: an autopsy case. Acta Neuropathol 2000;99:680–84
    CrossRefPubMed
  102. ↵
    Pizzolato GP, Sztajzel R, Burkhardt K, et al. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. Neurology 1998;50:1154–57
    Abstract/FREE Full Text
  103. ↵
    Bartynski WS, Boardman JF. Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol.2008;29:447–55
    Abstract/FREE Full Text
  104. ↵
    Geraghty JJ, Hoch DB, Robert ME, et al. Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991;41:1145–47
    Abstract/FREE Full Text
  105. ↵
    Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–46
    Abstract
  106. Lin JT, Wang SJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04
    Abstract/FREE Full Text
  107. ↵
    Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90
    Abstract
  108. ↵
    Shbarou RM, Chao NJ, Morgenlander JC. Cyclosporin A-related cerebral vasculopathy. Bone Marrow Transplant 2000;26:801–04
    CrossRefPubMed
  109. ↵
    Mellion ML, Rizvi S. Spontaneous bilateral carotid artery dissection and posterior reversible encephalopathy syndrome. Neurology 2005;65:1990
    FREE Full Text
  110. ↵
    Apollon KM, Robinson JN, Schwartz RB, et al. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol 2000;95:1017–19
    CrossRefPubMedWeb of Science
  111. ↵
    Lewis DH, Eskridge JM, Newell DW, et al. Brain SPECT and the effect of cerebral angioplasty in delayed ischemia due to vasospasm. J Nucl Med 1992;33:1789–96
    Abstract/FREE Full Text
  112. ↵
    Sugawara Y, Ueda T, Kikuchi T, et al. Hyperactivity of 99mTc-HMPAO within 6 hours in patients with acute ischemic stroke. J Nucl Med 2001;42:1297–302
    Abstract/FREE Full Text
  113. ↵
    Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72
    PubMedWeb of Science
  114. ↵
    Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30
    Abstract/FREE Full Text
  115. ↵
    Engelter ST, Petrella JR, Alberts MJ, et al. Assessment of cerebral microcircu-lation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491–93
    PubMed
  116. ↵
    Casey SO, McKinney A, Teksam M, et al. CT perfusion imaging in the management of posterior reversible encephalopathy. Neuroradiology 2004;46:272–76
    CrossRefPubMed
  117. ↵
    Eichler FS, Wang P, Wityk RJ, et al. Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002;23:833–37
    Abstract/FREE Full Text
  118. ↵
    Russell MT, Nassif AS, Cacayorin ED, et al. Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings. Magn Reson Imaging 2001;19:129–32
    CrossRefPubMedWeb of Science
  119. ↵
    Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507–10
    Abstract/FREE Full Text
  120. ↵
    Dinsdale HB. Hypertensive encephalopathy. Neurol Clin 1983;1:3–16
    PubMed
  121. ↵
    Coughlin WF, McMurdo SK, Reeves T. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr 1989;13:572–76
    PubMedWeb of Science
  122. ↵
    Toole JF. Lacunar syndromes and hypertensive encephalopathy. In: Toole JF, ed. Cerebrovascular Disorders. 5th ed. New York: Raven;1999 :342–55
  123. ↵
    Zwienenberg-Lee M, Muizelaar JP. Clinical pathophysiology of traumatic brain injury. In: HR W, ed. Youmans Neurological Surgery. 5th ed. Philadelphia: Saunders;2004 :5039–64
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 29 (6)
American Journal of Neuroradiology
Vol. 29, Issue 6
June 2008
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
W.S. Bartynski
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
American Journal of Neuroradiology Jun 2008, 29 (6) 1036-1042; DOI: 10.3174/ajnr.A0928

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features
W.S. Bartynski
American Journal of Neuroradiology Jun 2008, 29 (6) 1036-1042; DOI: 10.3174/ajnr.A0928
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Imaging Patterns in PRES
    • Basic Clinical Features of Neurotoxicity with PRES
    • Advanced Imaging in PRES
    • The Controversy over the Mechanism of PRES
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement
  • Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment
  • Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine
  • Delayed Leukoencephalopathy: A Rare Complication after Coiling of Cerebral Aneurysms
  • Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement
  • Encephalopathy in a kidney transplant recipient
  • Posterior reversible encephalopathy syndrome due to hypercalcaemia: a rare cause
  • Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
  • Reversible brain lesion following growth hormone replacement therapy in an adolescent
  • Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)
  • Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome
  • Republished: Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage
  • Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations
  • Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study
  • Utility and Significance of Gadolinium-Based Contrast Enhancement in Posterior Reversible Encephalopathy Syndrome
  • Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case
  • Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma
  • Posterior reversible encephalopathy syndrome with thalamic involvement during vasopressor treatment of vertebrobasilar vasospasm after subarachnoid hemorrhage
  • Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES)
  • Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels
  • Reversible cerebral vasoconstriction syndrome: a rare cause of postpartum headache
  • Neuroimaging Features and Predictors of Outcome in Eclamptic Encephalopathy: A Prospective Observational Study
  • Clinical Reasoning: Progressive visuospatial problems in a 71-year-old man
  • The challenges of antiphospholipid syndrome: experience from diagnosis to self-care
  • Lesson of the month (2): All that glitters is not stroke
  • Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia
  • Imaging Characteristics of Ischemic Strokes Related to Patent Foramen Ovale
  • Clinicopathologic and MRI Characteristics of Presumptive Hypertensive Encephalopathy in Two Cats and Two Dogs
  • Posterior Reversible Encephalopathy Syndrome: More Than Meets the Eye
  • Changes in Ophthalmic Artery Doppler Indices in Hypertensive Disorders During Pregnancy
  • Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
  • First reported case of posterior reversible encephalopathy syndrome occurring in a weightlifter
  • The many faces of posterior reversible encephalopathy syndrome
  • Neurotoxicology: Five new things
  • Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic Illness
  • Posterior reversible encephalopathy syndrome: the importance of early diagnosis
  • Multimodal Imaging of Reversible Cerebral Vasoconstriction Syndrome: A Series of 6 Cases
  • The posterior reversible encephalopathy syndrome in HIV infection
  • Reversible Posterior Leukoencephalopathy in a Venomous Snake (Bothrops asper) Bite Victim
  • A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the 'Royal Malady'
  • Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma
  • Reversible Cerebral Vasoconstriction Syndrome: Treatment with Combined Intra-Arterial Verapamil Infusion and Intracranial Angioplasty
  • Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
  • The posterior reversible encephalopathy syndrome: what's certain, what's new?
  • Suspicious Neuroimaging Pattern of Thrombotic Microangiopathy
  • Life imitates art: Anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy
  • Influenza A Encephalopathy, Cerebral Vasculopathy, and Posterior Reversible Encephalopathy Syndrome: Combined Occurrence in a 3-Year-Old Child
  • Isolated Acute Nontraumatic Cortical Subarachnoid Hemorrhage
  • ASYMPTOMATIC SPINAL CORD INVOLVEMENT IN POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
  • Reversible cerebral vasoconstriction syndrome
  • Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
  • Reversible posterior leukoencephalopathy syndrome caused by hanging
  • MR Imaging Findings of Medulla Oblongata Involvement in Posterior Reversible Encephalopathy Syndrome Secondary to Hypertension
  • Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Arteries
  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Veins
  • Clinical Translation of Hyperpolarized 13C Metabolic Probes for Glioma Imaging
Show more Review Articles

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire